SIGN UP
LOG IN
Why RH Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Benzinga·06/13/2025 09:08:07
Listen to the news
Shares of RH (NYSE:RH) rose sharply in today's pre-market trading as the company reported upbeat earnings for the first quarter and announced that it is maintaining its current FY25 guidance despite uncertainty surrounding tariffs and macroeconomic events.
RH reported first-quarter revenue of $813.95 million, missing the consensus estimate of $818.12 million, according to Benzinga Pro. The luxury retailer reported first-quarter adjusted earnings of 13 cents per share, surpassing analyst estimates calling for a loss of nine cents per share.
RH said it sees second-quarter revenue growth of 8% to 10%, and full-year 2025 revenue growth of 10% to 13%.
RH shares jumped 18.2% to $208.98 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- Houston American Energy Corp. (NYSE:HUSA) surged 140.3% to $16.87 in pre-market trading after gaining over 30% on Thursday.
- U.S. Energy Corp. (NASDAQ:USEG) shares jumped 62% to $2.30 in pre-market trading after adding 3% on Thursday.
- Indonesia Energy Corporation Limited (NASDAQ:INDO) jumped 42.4% to $5.08 in pre-market trading after gaining 10% on Thursday.
- Crown LNG Holdings Limited (NASDAQ:CGBS) gained 42.4% to $0.12 in pre-market trading after gaining 12% on Thursday.
- Trio Petroleum Corp. (NYSE:TPET) climbed 39.1% to $1.70 in pre-market trading after declining around 5% on Thursday.
- Nine Energy Service, Inc. (NYSE:NINE) rose 23.8% to $0.7285 in pre-market trading after gaining 4% on Thursday.
- EON Resources Inc. (NYSE:EONR) rose 22.3% to $0.6016 in pre-market trading.
- ParaZero Technologies Ltd. (NASDAQ:PRZO) surged 19.7% to $1.40 in pre-market trading.
- Transocean LTD (NYSE:RIG) gained 10% to $3.53 in pre-market trading.
Losers
- Sharplink Gaming Inc (NASDAQ:SBET) shares tumbled 64.4% to $11.60 in pre-market trading after falling 12% on Thursday.
- Rein Therapeutics Inc (NASDAQ:RNTX) dipped 18.5% to $1.60 in pre-market trading after the company announced it paused enrollment and patient dosing at its clinical trial sites in the US foe its Phase 2 RENEW trial of LTI-03.
- Greenlane Holdings Inc (NASDAQ:GNLN) shares fell 15% to $0.013 in pre-market trading after jumping 100% on Thursday.
- Healthcare Triangle Inc (NASDAQ:HCTI) declined 14.3% to $0.026 in pre-market trading after jumping 226% on Thursday.
- ReShape Lifesciences Inc (NASDAQ:RSLS) fell 12.5% to $2.72 in pre-market trading. ReShape Lifesciences jumped over 35% on Thursday after the company announced it signed an exclusive U.S. distribution agreement with Recon Supply to distribution ReShape’s portfolio across VA and DoD Healthcare Systems.
- Traws Pharma Inc (NASDAQ:TRAW) dipped 11.7% to $1.59 in pre-market trading.
- bioAffinity Technologies Inc (NASDAQ:BIAF) declined 10.3% to $0.27 in pre-market trading after gaining around 4% on Thursday.
- VEON Ltd (NASDAQ:VEON) declined 9.9% to $42.36 in pre-market trading after jumping 5% on Thursday.
- FibroGen Inc. (NASDAQ:FGEN) fell 3.9% to $0.30 in pre-market trading after the company reported a 1-for-25 reverse stock split
- Adobe Inc (NASDAQ:ADBE) fell 1.8% to $406.55 in pre-market trading. Adobe reported better-than-expected second-quarter financial results and raised its FY25 guidance.
Now Read This:
Photo via Shutterstock
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.